Author:
Sharma Shivani,Kumar Saroj,Tomar Manendra Singh,Chauhan Divya,Kulkarni Chirag,Rajput Swati,Sadhukhan Sreyanko,Porwal Konica,Guha Rajdeep,Shrivastava Ashutosh,Gayen Jiaur R.,Kumar Navin,Chattopadhyay Naibedya
Funder
Science and Engineering Research Board
Central Drug Research Institute
Council of Scientific and Industrial Research
Reference73 articles.
1. Treatment of secondary hyperparathyroidism in non-dialysis CKD: an appraisal;Ketteler;Nephrol. Dial. Transplant.,2022
2. Renal association commentary on the KDIGO (2017) clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of CKD-MBD;Burton;BMC Nephrol.,2018
3. Calcium-sensing receptor activation in chronic kidney disease: effects beyond parathyroid hormone control;Massy;Semin. Nephrol.,2014
4. The clinical consequences of secondary hyperparathyroidism: focus on clinical outcomes;Hörl;Nephrol. Dial. Transplant.,2004
5. The calcium-sensing receptor in bone;Yamaguchi;J. Bone Miner. Metab.,2008